Eledon Reports Data from Ongoing Phase 1b Trial Evaluating Tegoprubart in Patients Undergoing Kidney Transplantation at World Congress of Nephrology
Results from three participants demonstrated no incidence of acute rejection at durations of 56, 154, and 232 days Strong graft function observed in all three participants with mean eGFRs above 70... | March 31, 2023
United Kingdom Stephen Jasper David Alexandrec Gros World Congress Exchange Commission Gilmartin Group
Source: marketscreener.com